The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...
The "Big 3" PBMs also separately generated an estimated $1.4 billion of income from spread pricing, FTC finds.
The National Association of Chain Drug Stores is praising the Federal Trade Commission's (FTC) unanimous, 5-0, vote on Monday to release the second interim staff report on the FTC's study of big ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
Pharmacy benefit managers "are raking in billions in excess revenue—$7.3 billion over just five years—while squeezing ...
Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...
Denali Therapeutics showcases its BBB platform at J.P. Morgan Conference, highlighting DNL310's Hunter syndrome progress and plans for commercialization.
The report is the latest indictment of America’s broken healthcare system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback